Assort Health recently raised $120 million in a Series C funding round led by Menlo Ventures, propelling the healthcare AI startup to a $1.2 billion valuation. The latest injection brings the company's total funding to more than $222 million. Existing investors including Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital also participated in the round, which places Menlo Ventures partner JP Sanday on Assort's board.
The capital influx comes amid a 20x revenue surge for Assort over the last 15 months, driven by commercial demand for automated administrative infrastructure. Healthcare providers currently spend nearly twice as much on administration as they do on direct patient care, resulting in a $1.1 trillion annual administrative burden. Assort aims to capture this market by targeting the patient intake bottleneck, scaling its voice and digital AI agents to automate scheduling, referrals, medical refills, and billing.
The platform utilizes a proprietary AI model called Synapse to learn specific specialty workflows across deployments and simulate edge cases. Its product suite spans four core automated services connected by a central data layer called Patient Journey Memory, which retains patient context across multiple care interactions. This underlying dataset has been trained on more than 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways to automate provider-specific workflows.
Assort is leveraging the new capital to fund an expansion into larger health system operations, moving beyond its core base of provider groups into community-based healthcare organizations and academic medical centers. Providers like John Muir Health, Boston Bone and Joint Institute, and MDCS Dermatology have already deployed the technology to manage complex ambulatory operations. Assort Founder and Co-CEO Jon Wang stated, "Provider groups know it, and the smart ones aren't buying another point solution. They want one partner with the capital and the engineering depth to transform how they operate over the long run."
